TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Eurocine Vaccines AB
Closing information (x1000 EUR)
Closing information | 2023/06 (consolidated) | 2022/06 (consolidated) | 2021/06 (consolidated) |
Turnover | 0 | 0 | |
Financial expenses | 0 | 1 | |
Earnings before taxes | -1,887 | -1,803 | |
EBITDA | -1,887 | -1,802 | |
Total assets | 1,760 | 3,532 | |
Current assets | 1,760 | 3,532 | |
Current liabilities | 301 | 380 | |
Equity capital | 1,459 | 3,152 | |
- share capital | 407 | 195 | |
Employees (average) | 3 | 4 | 4 |
Financial ratios
Fiscal year | 2023/06 (consolidated) | 2022/06 (consolidated) | 2021/06 (consolidated) |
Solvency | 82.9% | 89.2% | |
Turnover per employee | 0 | 0 | |
Profit as a percentage of turnover | |||
Return on assets (ROA) | -107.2% | -51.0% | |
Current ratio | 584.7% | 929.5% | |
Return on equity (ROE) | -129.3% | -57.2% | |
Change turnover | 0 | 0 | |
Change turnover % | |||
Chg. No. of employees | -1 | 0 | 1 |
Chg. No. of employees % | -25% | 0% | 33% |
Total value of public sale
Fiscal year | 2023/06 (consolidated) | 2022/06 (consolidated) | 2021/06 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.